Search Results

• • 12 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• The global landscape of smallpox vaccination history and implications for current and future orthopoxvirus susceptibility: a modelling study.

  Authors:Juliana C Taube, Eva C Rest, James O Lloyd-Smith, and Shweta BansalFrom:The Lancet Infectious Diseases (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 2023383 words Report, Brief articl...

   Abstract Only

• Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain.

  Authors:Clara Suñer, Maria Ubals, Eloy José Tarín-Vicente, Adrià Mendoza, Andrea Alemany, Águeda Hernández-Rodríguez, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 20231,083 words Clinical report

   Abstract Only

• Understanding clinical outcome measures reported in HIV pregnancy studies involving antiretroviral-naive and antiretroviral-experienced women.

  Authors:Ahizechukwu C Eke, Rahel D Gebreyohannes, and Anna M PowellFrom:The Lancet Infectious Diseases (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 2023241 words Brief article

   Abstract Only

• Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial.

  Authors:Victor Kande Betu Kumeso, Wilfried Mutombo Kalonji, Sandra Rembry, Olaf Valverde Mordt, Digas Ngolo Tete, Adeline Prêtre, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 2023869 words Report

   Abstract Only

• Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.

  Authors:Nicole Ngai Yung Tsang, Hau Chi So, Benjamin J Cowling, Gabriel M Leung, and Dennis Kai Ming IpFrom:The Lancet Infectious Diseases (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 2023645 words Clinical report

   Abstract Only

• Post-tuberculosis sequelae in children and adolescents: a systematic review.

  Authors:Vanessa Igbokwe, Lisa C Ruby, Ayten Sultanli, and Sabine BélardFrom:The Lancet Infectious Diseases (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 2023286 words Brief article

   Abstract Only

• TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trial.

  Authors:Man-Fung Yuen, Rozalina Balabanska, Emmanuelle Cottreel, Ethan Chen, Dan Duan, Qiudi Jiang, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 2023739 words Article

   Abstract Only

• Successful use of interferon alfa-2a for persistent parvovirus B19 infection.

  Authors:Trine H Mogensen, Morten Kelder Skouboe, and Ingolf MølleFrom:The Lancet Infectious Diseases (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 2023225 words Brief article

   Abstract Only

• Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial.

  Authors:Ephraim L Tsalik, Nadine G Rouphael, Ruxana T Sadikot, Maria C Rodriguez-Barradas, Micah T McClain, Dana M Wilkins, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 2023961 words Article

   Abstract Only

• Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.

  Authors:José Domínguez, Martin J Boeree, Emmanuelle Cambau, Dumitru Chesov, Francesca Conradie, Vivian Cox, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 20231,031 words Article

   Abstract Only

• Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial.

  Authors:Walter R Taylor, Peter Olupot-Olupot, Marie A Onyamboko, Pimnara Peerawaranun, Winifred Weere, Cate Namayanja, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 2023774 words Article

   Abstract Only

• Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021--March, 2022: a national, observational, test-negative, case-control study.

  Authors:Annabel A Powell, Freja Kirsebom, Julia Stowe, Mary E Ramsay, Jamie Lopez-Bernal, Nick Andrews, et al.From:The Lancet Infectious Diseases (Vol. 23, Issue 4) Peer-Reviewed

  Apr. 2023566 words Article

   Abstract Only